For the Development of Sulphated Lactosyl Archaeol (SLA) and Sulfated Lactosyl Archaeosomes to be delivered to Human Health Therapeutics located at 1200 Montreal Rd, Bldg. M54 (Ottawa Ont
Solicitation number 20-58090
Publication date
Closing date and time 2020/12/29 14:00 EST
Last amendment date
Description
The National Research Council of Canada (NRC) requires a biological process to be developed and used for the production of archaeosomes composed of sulfated lactosyl archaeol (SLA; 6’-sulfate-β-D-Galp-(1,4)-β-D-Glcp-(1,1)-archaeol. Archaeosomes should be of average size no greater than 200 nm and should be composed of sulfated lactosyl archaeol (R stereoisomer).
Contract duration
Refer to the description above for full details.
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
Contact information
Contracting organization
- Organization
-
National Research Council Canada
- Address
-
100 Sussex DrOttawa, Ontario, K1A0R6Canada
- Contracting authority
- Cassidy, Stephen
- Phone
- 613-993-0851
- Email
- Steve.Cassidy@nrc-cnrc.gc.ca
- Address
-
1200 Montreal RdOttawa, ON, K1A 0R6CA
Buying organization(s)
- Organization
-
National Research Council Canada
- Address
-
100 Sussex DrOttawa, Ontario, K1A0R6Canada
Bidding details
Full details regarding this tender opportunity are available in the documents below. Click on the document name to download the file. Contact the contracting officer if you have any questions regarding these documents.
Document title | Amendment no. | Language | Unique downloads | Date added |
---|---|---|---|---|
acan_-_biovectra_inc-dec11.pdf |
English
|
18 | ||
acan_-_biovectra_inc_final_f.pdf |
French
|
7 |
Access the Getting started page for details on how to bid, and more.